Danaher Corporation (NYSE:DHR) — Market Cap & Net Worth
Market Cap & Net Worth: Danaher Corporation (DHR)
Danaher Corporation (NYSE:DHR) has a market capitalization of $127.92 Billion ($127.92 Billion) as of June 17, 2026. Listed on the NYSE stock exchange, this USA-based company holds position #181 globally and #98 in its home market, demonstrating a -1.74% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Danaher Corporation's stock price $181.10 by its total outstanding shares 706349563 (706.35 Million). Review Danaher Corporation balance sheet liabilities to assess the company's total debt and financial obligations.
Danaher Corporation Market Cap History: 2015 to 2026
Danaher Corporation's market capitalization history from 2015 to 2026. Data shows growth from $27.09 Billion to $127.92 Billion (16.13% CAGR).
Index Memberships
Danaher Corporation is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
S&P 500 Index
GSPC
|
$62.29 Trillion | 0.26% | #82 of 503 |
|
S&P 100
OEX
|
$44.62 Trillion | 0.37% | #67 of 101 |
Weight: Danaher Corporation's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Danaher Corporation Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Danaher Corporation's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
6.79x
Danaher Corporation's market cap is 6.79 times its annual revenue
Latest Price to Earnings (P/E) Ratio
41.59x
Danaher Corporation's market cap is 41.59 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $27.09 Billion | $14.43 Billion | $2.60 Billion | 1.88x | 10.43x |
| 2016 | $47.01 Billion | $16.88 Billion | $2.55 Billion | 2.78x | 18.41x |
| 2017 | $56.42 Billion | $18.33 Billion | $2.49 Billion | 3.08x | 22.64x |
| 2018 | $63.08 Billion | $17.05 Billion | $2.65 Billion | 3.70x | 23.79x |
| 2019 | $94.33 Billion | $17.91 Billion | $2.56 Billion | 5.27x | 36.89x |
| 2020 | $137.10 Billion | $22.28 Billion | $3.65 Billion | 6.15x | 37.60x |
| 2021 | $203.68 Billion | $29.45 Billion | $6.43 Billion | 6.92x | 31.66x |
| 2022 | $164.94 Billion | $26.64 Billion | $7.21 Billion | 6.19x | 22.88x |
| 2023 | $162.90 Billion | $23.89 Billion | $4.74 Billion | 6.82x | 34.34x |
| 2024 | $162.14 Billion | $23.88 Billion | $3.90 Billion | 6.79x | 41.59x |
Competitor Companies of DHR by Market Capitalization
Companies near Danaher Corporation in the global market cap rankings as of June 17, 2026.
Key companies related to Danaher Corporation by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #127 globally with a market cap of $177.98 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #622 globally with a market cap of $44.18 Billion USD.
- LONZA GROUP UNSP.ADR 1/10 (F:LO3A): Ranked #662 globally with a market cap of $41.04 Billion USD ( €35.10 Billion EUR).
- Agilent Technologies Inc (NYSE:A): Ranked #740 globally with a market cap of $36.96 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #127 | Thermo Fisher Scientific Inc | NYSE:TMO | $177.98 Billion | $473.72 |
| #622 | IDEXX Laboratories Inc | NASDAQ:IDXX | $44.18 Billion | $570.00 |
| #662 | LONZA GROUP UNSP.ADR 1/10 | F:LO3A | $41.04 Billion | €54.50 |
| #740 | Agilent Technologies Inc | NYSE:A | $36.96 Billion | $130.59 |
Danaher Corporation Historical Marketcap From 2015 to 2026
Between 2015 and today, Danaher Corporation's market cap moved from $27.09 Billion to $ 127.92 Billion, with a yearly change of 16.13%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $127.92 Billion | -20.89% |
| 2025 | $161.70 Billion | -0.27% |
| 2024 | $162.14 Billion | -0.46% |
| 2023 | $162.90 Billion | -1.24% |
| 2022 | $164.94 Billion | -19.02% |
| 2021 | $203.68 Billion | +48.57% |
| 2020 | $137.10 Billion | +45.34% |
| 2019 | $94.33 Billion | +49.55% |
| 2018 | $63.08 Billion | +11.80% |
| 2017 | $56.42 Billion | +20.01% |
| 2016 | $47.01 Billion | +73.51% |
| 2015 | $27.09 Billion | -- |
End of Day Market Cap According to Different Sources
On Jun 16th, 2026 the market cap of Danaher Corporation was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $127.92 Billion USD |
| MoneyControl | $127.92 Billion USD |
| MarketWatch | $127.92 Billion USD |
| marketcap.company | $127.92 Billion USD |
| Reuters | $127.92 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Danaher Corporation
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. It operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides bioprocessing technologies, consumables, services, and solutions that advance, accelerate, and integrate the deve… Read more